2Badesch DB, Abinan SH,Simonneau G,et al. Medical therapy for pulmonary arterial hypertension: updated ACCP evidence- based clinical practice guidelines. Chest. 2007, 131: 1917- 1928.
3Humbert M. Morrell NW. Archer SL, et al. Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol, 2004.43( 12 Suppl S):13S-24S.
4Farber HW. l.oscalzo J. Pulmonary arterial hypertension. N Engl J Mech2004.351:1655-1665.
5Mooi WJ, Grunberg K. Histopathology of pulmonary hypertensive diseases. Curr Diagn Pathol, 2006.12 : 429-440.
6Wagenvoort CA. Classification of pulmonary vascular lesions in congenital and acquired heart disease. Adv Cardiol,1974. 11:18- 55.
8Mehta NJ,Khan IA,Mehta RN,et al. HIV related pulmonary hypertension:analytic review of 131 cases. Chest, 2000, 118: 1133-1141.
9Nicolls MR, Taraseviciene--Stewart L, Rai PR, et al. Autoimmunity and pulmonary hypertension :a perspective. Eur Respir J,2005,26 : 1110-1118.
10Yaginuma G, Mohri H, Takahashi T. Distrihution of arterial lesions and collateral pathways in the pulmonary hypertension of congenital heart disease:a computer aided reconstruction study. Thorax,1990,45:586-590.
